This Week in Neuroblastoma – 12/17/12

This week we’re introducing you to two strong families – both grieving the loss of their sons, and working through their sadness to create hope for those who are in similar situations.

Here’s this week’s links…

Kids – Why We Fight

Teddy Berger-Greer

At three and a half years old, surrounded by family and love, Teddy Berger-Greer passed away on December 13, 2012. Teddy’s parents Jim and Clarence are heavy hearted, and struggling to help their older son, Leo, understand his brother’s death. As a tribute to his son, Jim wrote the story of how he met Teddy’s mother and fell in love with her. It’s an inspirational read that offers a bit of hope in the family’s time of need. Jim writes: “It was that same sun that came out yesterday and took him away from us. That same sun that cast its light on our wedding day. Living and dying, are they really so different? We were there for Teddy’s entry in the world, and his exit from it. And in between, mostly smiles.”

Non-Profits / Events / News

Ben Towne Foundation Offers Hope

Ben Towne was two years old when he was diagnosed with stage IV neuroblastoma. He endured a year and a half of treatments before succumbing to untreatable relapsed cancer. Ben was a loving little boy, who loved matchbox cars, tennis, golf and Husky sports. Ben’s parents, Carin and Jeff Towne, were inspired by their son’s journey to start the Ben Towne Foundation in 2010. Watching their son suffer through chemo and radiation opened Jeff and Carin’s eyes to a painful reality, and the foundation’s goal is to find other means of treatment that will be gentler on cancer patients’ bodies. Thanks to the diligent work at the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute, a new trial is being opened up that offers hope for patients with relapsed acute lymphoblastic leukemia (ALL).

You can sign up to receive these weekly articles in your email. Sign up below…

Mind if we hang out
in your inbox?

We only email once or twice a month, always relevant to how we're working to beat neuroblastoma and other childhood cancers.

Thank you for subscribing!

Something went wrong.